A role for PLCγ2 in platelet activation by homocysteine

Journal of Cellular Biochemistry

Volumn 100, Issue 5, 2007, Pages 1255-1265

  Leoncini, Giuliana ^a   Bruzzese, Debora ^a   Signorello, Maria Grazia ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Homocysteine; p60src; p72syk; Platelet activation; PLC 2

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ACETYLCYSTEINE; CALCIUM ION; HOMOCYSTEINE; INDOMETACIN; OXYGEN RADICAL; PHOSPHOLIPASE C GAMMA2; PICEATANNOL; PROTEIN KINASE C; PROTEIN KINASE P60; PROTEIN P72; REACTIVE OXYGEN METABOLITE; THROMBOXANE A2; TYROSINE; CALCIUM; PHOSPHATASE; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; DRUG EFFECT; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; PHOSPHORYLATION;

CALCIUM; HOMOCYSTEINE; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ONCOGENE PROTEIN PP60(V-SRC); OXIDATIVE STRESS; PHOSPHOLIPASE C GAMMA; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PLATELET ACTIVATION; PLATELET AGGREGATION; PROTEIN-TYROSINE KINASES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TYROSINE;

EID: 33947576806     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21123     Document Type: Article

References (48)

1. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595.
2. Bachelot C, Cano E, Grelac F, Saleun S, Druker BJ, Levy-Toledano S, Fischer S, Rendu F. 1992. Functional implications of tyrosine protein phosphorylation in platelets. Simultaneous studies with different agonists and inhibitors. Biochem J 84:923-981.
3. Born GVR. 1962. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927-929.
4. Brandt R, Keston AS. 1965. Synthesis of diacetyldichloro-fluorescin: A stable reagent for fluorimetric analysis. Anal Biochem 11:6-9.
5. Brumell JH, Burkhardt AL, Bolen JB, Grinstein S. 1996. Endogenous reactive oxygen intermediates activate tyrosine kinases in human neutrophils. J Biol Chem 271:1455-1461.
6. Canobbio I, Bertoni A, Lova P, Paganini S, Hirsch E, Sinigaglia F, Balduini C, Torti M. 2001. Platelet activation by von Willebrand factor requires coordinated signaling through thromboxane A2 and Fc gamma IIA receptor. J Biol Chem 276:26022-26029.
7. Carpenter G, Ji Q. 1999. Phospholipase C-γ as a signal-transducing element. Exp Cell Res 253:15-24.
8. Cattaneo M. 1999. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 81:165-176.
9. Clark EA, Shattil SJ, Ginsberg MH, Bolen J, Brugge JS. 1994. Regulation of the protein tyrosine kinase pp72syk by platelet agonists and the integrin alpha IIb beta 3. J Biol Chem 269:28859-28864.
10. Dardik R, Varon D, Tamarin I, Zivelin A, Salomon O, Shenkman B, Savion N. 2000. Homocysteine and oxidized low density lipoprotein enhanced platelet adhesion to endothelial cells under flow conditions: Distinct mechanisms of thrombogenic modulation. Thromb Haemost 83:338-344.
11. de Jong SC, van den Berg M, Rauwerda JA, Stehouwer CD. 1998. Hyperhomocysteinemia and atherothrombotic disease. Semin Thromb Hemost 24:381-385.
12. Domagala TB, Undas A, Libura M, Szczeklik A. 1998. Pathogenesis of vascular disease in hyperhomocysteinaemia. J Cardiovasc Risk 5:239-247.
13. Ermak G, Davies KJ. 2002. Calcium and oxidative stress: From cell signalling to cell death. Mol Immunol 38:713-721.
14. Golden A, Brugge JS. 1989. Thrombin treatment induces rapid changes in tyrosine phosphorylation in platelets. Proc Natl Acad Sci USA 6:1-5.
15. Hardwick JS, Sefton BM. 1995. Activation of the Lck tyrosine protein kinase by hydrogen peroxide requires the phosphorylation of Tyr-394. Proc Natl Acad Sci USA 92:4527-4531.
16. 2 and vanadate in vitro. Biochem Biophys Res Commun 188:773-779.
17. Jeremy JY, Rowe D, Emsley AM, Newby AC. 1999. Nitric oxide and the proliferation of vascular smooth muscle cells. Cardiovasc Res 43:580-594.
18. Leloir LF, Cardini CE. 1957. Characterization of phosphorus compounds by acid liability. In: Colowick SP, Kaplan NO, editors. Methods in Enzymology, Vol. 3. New York: Academic Press. pp 840-850.
19. Leoncini G, Maresca M, Buzzi E, Piana A, Armani U. 1990. Platelets of patients affected with Essential Thrombocythemia are abnormal in plasma membrane and adenine nucleotide content. Eur J Haematol 44:116-120.
20. Leoncini G, Maresca M, Colao C. 1991. Oxidative metabolism of human platelets. Biochem Int 25:647-655.
21. Leoncini G, Pascale R, Signorello MG. 2003. Effects of homocysteine on L-arginine transport and nitric oxide formation in human platelets. Eur J Clin Invest 33:713-719.
22. 2 pathway in homocysteine treated platelets. J Thromb Haemost 4:209-216.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurements with the Folin phenol reagent. J Biol Chem 193:265-275.
24. Mutus B, Rabini RA, Staffolani R, Ricciotti R, Fumelli P, Moretti N, Martarelli D, Mazzanti L. 2001. Homocysteine-induced inhibition of nitric oxide production in platelets: A study on healthy and diabetic subjects. Diabetologia 44:979-982.
25. Nakamura S, Yamamura H. 1989. Thrombin and collagen induce rapid phosphorylation of a common set of cellular proteins on tyrosine in human platelets. J Biol Chem 64:89-91.
26. Poole A, Gibbins JM, Turner M, van Vugt MJ, van de Winkel JG, Saito T, Tybulewicz VL, Watson SP. 1997. The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J 16:2333-2341.
27. Qin S, Inazu T, Yamamura H. 1995. Activation and tyrosine phosphorylation of p72syk as well as calcium mobilization after hydrogen peroxide stimulation in peripheral blood lymphocytes. Biochem J 308:347-352.
28. Qin S, Minami Y, Hibi M, Kurosaki T, Yamamura H. 1997. Syk-dependent and -independent signaling cascades in B cells elicited by osmotic and oxidative stress. J Biol Chem 272:2098-2103.
29. Razdan K, Hellums JD, Kroll MH. 1994. Shear-stress-induced von Willebrand factor binding to platelets causes the activation of tyrosine kinase(s). Biochem J 302:681-686.
30. Rezaul K, Sada K, Yamamura H. 1998. Involvement of reactive oxygen intermediates in lectin-induced protein-tyrosine phosphorylation of Syk in THP-1 cells. Biochem Biophys Res Commun 246:863-867.
31. Rosado JA, Redondo PC, Salido GM, Gomez-Arteta E, Sage SO, Pariente JA. 2004. Hydrogen peroxide generation induces pp60src activation in human platelets: Evidence for the involvement of this pathway in store-mediated calcium entry. J Biol Chem 279:1665-1675.
32. Rotondo S, Evangelista V, Manarini S, de Gaetano G, Cerletti C. 1997. Different requirement of intracellular calcium and protein kinase C for arachidonic acid release and serotonin secretion in cathepsin G-activated platelets. Thromb Haemost 78:919-925.
33. Salmeen A, Andersen JN, Myers MP, Meng TC, Hinks JA, Tonks NK, Barford D. 2003. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423:769-773.
34. Schieven GL, Kirihara JM, Burg DL, Geahlen RL, Ledbetter JA. 1993a. p72syk tyrosine kinase is activated by oxidizing conditions that induce lymphocyte tyrosine phosphorylation and Ca2+ signals. J Biol Chem 268:16688-16692.
35. Schieven GL, Kirihara JM, Myers DE, Ledbetter JA, Uckun FM. 1993b. Reactive oxygen intermediates activate NF-kappa B in a tyrosine kinase-dependent mechanism and in combination with vanadate activate the p56lck and p59fyn tyrosine kinases in human lymphocytes. Blood 82:1212-1220.
36. Schieven GL, Mittler RS, Nadler SG, Kirihara JM, Bolen JB, Kanner SB, Ledbetter JA. 1994. ZAP-70 tyrosine kinase, CD45, and T cell receptor involvement in UV- and H2O2-induced T cell signal transduction. J Biol Chem 269:20718-20726.
37. Signorello MG, Pascale R, Leoncini G. 2002. Effect of homocysteine on arachidonic acid release in human platelets. Eur J Clin Invest 32:279-284.
38. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J. 1993. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91:308-318.
39. Taniguchi T. 1995. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251-255.
40. 2+ mobilization in platelets. J Biol Chem 268:2277-2279.
41. Torti M, Bertoni A, Canobbio I, Sinigaglia F, Lapetina EG, Balduini C. 1999. Rap1B and Rap2B translocation to the cytoskeleton by von Willebrand factor involves FcgammaII receptor-mediated protein tyrosine phosphorylation. J Biol Chem 274:13690-13697.
42. Townend J, O'Sullivan J, Wilde JT. 1998. Hyperhomocysteinaemia and vascular disease. Blood Rev 12:23-34.
43. Turner M, Mee PJ, Costello PS, Williams O, Price AA, Duddy LP, Furlong MT, Geahlen RL, Tybulewicz VL. 1995. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378:298-302.
44. Ullrich A, Schlessinger J. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 6:203-212.
45. Upchurch GR Jr., Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr, Loscalzo J. 1997. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272:17012-17017.
46. Yada T, Shimokawa H, Hiramatsu O, Kajita T, Shigeto F, Goto M, Ogasawara Y, Kajiya F. 2003. Hydrogen peroxide, an endogenous endothelium-derived hyperpolarizing factor, plays an important role in coronary autoregulation in vivo. Circulation 107:1040-1045.
47. Yoshizumi M, Abe J, Haendeler J, Huang Q, Berk BC. 2000. Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J Biol Chem 275:11706-11712.
48. Zor U, Ferber E, Gergely P, Szucs K, Dombradi V, Goldman R. 1993. Reactive oxygen species mediate phorbol ester-regulated tyrosine phosphorylation and phospholipase A2 activation: Potentiation by vanadate. Biochem J 295:879-888.